Cefditoren pivoxil
Product Description
BDR PHARMACEUTICALS INTERNATIONAL PVT.
-
IN
-
2015On CPHI since
-
1000 - 4999Employees
Company types
Specifications
BDR PHARMACEUTICALS INTERNATIONAL PVT.
-
IN
-
2015On CPHI since
-
1000 - 4999Employees
Company types
More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)
-
Product Capacitabine tablets 500 mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes capacitabine tablets 500 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information. -
Product Carboplatin injection 150 mg/ 450 mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes carboplatin injection 150 mg/ 450 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information. -
Product Caspofungin
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin. It belongs to antifungal apis category. Contact us for more information. -
Product Caspofungin 50 mg/70 mg - under development
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin 50 mg/70 mg - under development. It belongs to antifungal finish formulations products category. Contact us for more information. -
Product Caspofungin acetate
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin acetate. It belongs to antifungal apis category. Contact us for more information. -
Product Cefdinir
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefdinir. It belongs to cephalosporins apis products category. Contact us for more information. -
Product Cefepime + sulbactam for injection (1000 + 500) / (500 + 250) mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information. -
Product Cefepime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for m... -
Product Cefepime +amikacin injection (500 + 125) / (1000 + 250) / (2000 + 500) mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime +amikacin injection (500 + 125) / (1000 + 250) / (2000 + 500) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more infor... -
Product Cefepime hcl + l ? arginine
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime hcl + l ? arginine. It belongs to cephalosporins apis products category. Contact us for more information. -
Product Cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for... -
Product Cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us ...
BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)
-
Video BDR Pharmaceuticals INT'L PVT LTD at CPHI Worldwide 2018
Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance